Previous Article | Next Article 
Applied and Environmental Microbiology, December 2001, p. 5558-5567, Vol. 67, No. 12
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.12.5558-5567.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Degradation of Quercetin and Luteolin by
Eubacterium ramulus
Annett
Braune,1,2,*
Michael
Gütschow,3,
Wolfram
Engst,2 and
Michael
Blaut1,2
Abteilung Gastrointestinale
Mikrobiologie,1 Deutsches Institut
für Ernährungsforschung,2 D-14558
Bergholz-Rehbrücke, and Institut für Pharmazie,
Universität Leipzig, D-04103 Leipzig,3
Germany
Received 15 June 2001/Accepted 27 September 2001
 |
ABSTRACT |
The degradation of the flavonol quercetin and the flavone luteolin
by Eubacterium ramulus, a strict anaerobe of the human intestinal tract, was studied. Resting cells converted these flavonoids to 3,4-dihydroxyphenylacetic acid and
3-(3,4-dihydroxyphenyl)propionic acid, respectively. The conversion of
quercetin was accompanied by the transient formation of two
intermediates, one of which was identified as taxifolin based on its
specific retention time and UV and mass spectra. The structure of the
second intermediate, alphitonin, was additionally elucidated by
1H and 13C nuclear magnetic resonance analysis.
In resting-cell experiments, taxifolin in turn was converted via
alphitonin to 3,4-dihydroxyphenylacetic acid. Alphitonin, which was
prepared by enzymatic conversion of taxifolin and subsequent
purification, was also transformed to 3,4-dihydroxyphenylacetic acid.
The coenzyme-independent isomerization of taxifolin to alphitonin was
catalyzed by cell extract or a partially purified enzyme preparation of
E. ramulus. The degradation of luteolin by resting cells
of E. ramulus resulted in the formation of the
intermediate eriodictyol, which was identified by high-performance liquid chromatography and mass spectrometry analysis. The observed intermediates of quercetin and luteolin conversion suggest that the
degradation pathways in E. ramulus start with an
analogous reduction step followed by different enzymatic reactions
depending on the additional 3-hydroxyl group present in the flavonol structure.
 |
INTRODUCTION |
Flavonoids are polyphenolic
compounds which are present in foods and beverages of plant origin. The
daily intake of flavonoids calculated on the basis of the aglycones was
estimated to range from approximately 3 to 70 mg in different
countries, and it may well exceed these values in regions with a very
high intake of tea and vegetables (5, 10, 13). In vivo
data on absorption and metabolism after oral intake are contradictory.
However, a major part of ingested flavonoids are not absorbed and are
largely degraded by the intestinal microflora.
It was shown in vitro that flavonoids are potent antioxidants and
inhibitors of ubiquitous enzymes, and their anticarcinogenic properties
were demonstrated with different cell lines (for a review, see
reference 8). Due to these properties, flavonoids are
reported to protect against cancer, coronary heart disease, and stroke.
In order to judge the potential beneficial health effects of flavonoids
in humans, studies on their fate in the gastrointestinal tract,
including transformation by bacteria, are necessary. Intestinal
bacteria play important roles not only in deconjugation of flavonoids
but also in their further degradation. The bacterial metabolites, which
possibly exert biological activities different from those of the
original flavonoids, may be absorbed and further metabolized in the
human body. Therefore, it is essential to study their conversion by
intestinal bacteria and to identify and characterize the fermentation
products formed. Although some flavonoid-degrading species, their
substrates, and some of the final products are known (2, 15, 18,
22), information on the anaerobic degradation pathways,
intermediates, and the enzymes involved is lacking.
Eubacterium ramulus, a strict anaerobe resident in the human
intestinal tract, grows with quercetin-3-glucoside (isoquercitrin) as
the sole carbon and energy source. The only intermediates detected in
this degradation were quercetin and phloroglucinol, the fermentation products being 3,4-dihydroxyphenylacetic acid, butyrate, and acetate (20). Furthermore, E. ramulus was found to be
able to split the ring system of several other flavonols and flavones,
forming the corresponding hydroxyphenylacetic and
hydroxyphenylpropionic acids, respectively. Degradation pathways of
flavonols and flavones were proposed, which include reduction of the
heterocyclic C-ring of the aglycon, yielding dihydroflavonols and
flavanones, respectively, followed by ring fission. Cleavage of the
resulting chalcones might subsequently give rise to the respective
phenolic acids (19). E. ramulus was detected in
fecal samples from each of 20 persons tested at cell numbers which
average 0.16% of the total flora (21). Therefore,
E. ramulus may be considered a common inhabitant of the
human intestine and a key organism for flavonoid degradation in this habitat.
In order to test the proposed flavonoid degradation pathways, the
fermentation of the flavonol quercetin and the flavone luteolin by
resting cells of E. ramulus was studied. In this report we describe the detection and identification of intermediates of quercetin
and luteolin degradation, respectively.
 |
MATERIALS AND METHODS |
Organism.
E. ramulus strain wK1, previously
isolated from a human fecal sample (20), was used
throughout the study. The organism will be made available upon request.
Chemicals.
Quercetin, luteolin, and eriodictyol were
purchased from Roth (Karlsruhe, Germany), taxifolin was purchased from
Sigma (Deisenhofen, Germany), and 3,4-dihydroxyphenylacetic acid and
3-(3,4-dihydroxyphenyl)propionic acid were purchased from Fluka
(Deisenhofen, Germany). High-pressure liquid chromatographic
(HPLC)-grade methanol (Fluka) was used throughout the experiments.
Growth media and anoxic techniques.
The anoxic techniques
were essentially those of Hungate (11) and Bryant
(3). A gas phase of
N2-CO2 (80:20, vol/vol) was used. The anoxic workstation (MK 3; DW Scientific, Shipley, Great Britain) had a gas phase of
N2-CO2-H2
(80:10:10, vol/vol/vol). E. ramulus strain wK1
(20) was grown under strictly anoxic conditions in tubes
fitted with butyl-rubber stoppers and screw caps. The medium (ST
medium) contained the following compounds per liter: 9 g of
tryptically digested meat peptone, 1 g of proteose peptone, 3 g of meat extract, 4 g of yeast extract, 6 g of glucose,
3 g of NaCl, 2 g of
Na2HPO4, 0.5 ml of Tween
80, 0.25 g of cystine, 0.25 g of
L-cysteine-HCl, 0.1 g of
MgSO4 · 7 H2O, 5 mg of FeSO4 · 7 H2O,
and 3.4 mg of MnSO4 · 2
H2O. The pH after autoclaving at 121°C for 20 min was between 6.8 and 7.1.
Preparation of resting cell suspensions and degradation
experiments.
The E. ramulus cultures grown overnight in
ST medium were transferred into the anoxic workstation and were
prepared for centrifugation (10,000 × g, 15 min).
After centrifugation, the cells were washed once with 50 mM potassium
phosphate buffer (pH 6.9) containing either 1.4 mM cysteine or 5 mM
dithiothreitol, and the pellet was resuspended in the same buffer to an
optical density indicated in the experiments. Aliquots of this cell
suspension were each transferred into 250-ml serum bottles and used for
the resting-cell experiments.
Degradation experiments were performed by adding defined amounts of
flavonoids dissolved in dimethyl sulfoxide (DMSO) with a syringe. The
bottles were incubated at either 37 or 19°C in a water bath equipped
with a rotary shaker (120 rpm). At different times, aliquots were taken
with a syringe and immediately centrifuged (12,000 × g, 5 min), and the supernatant was directly analyzed by
HPLC. The pellets were lyophilized (Alpha 2-4; Christ, Osterode, Germany) and dissolved in dimethylformamide or methanol for
further analysis by HPLC. For a comparison, the supernatant and the
pellet together were lyophilized and dissolved in the same solvents for further analysis by HPLC.
Preparation of cell extracts and partially purified enzyme
preparations.
The cell extracts were prepared in the presence or
absence of oxygen at 4°C from E. ramulus cultures grown
overnight in ST medium supplemented with 0.1 mM quercetin. The cells
were centrifuged (10,000 × g, 15 min), washed once
with 50 mM potassium phosphate buffer (pH 6.9), resuspended in the same
buffer supplemented with DNase, and ruptured by twofold passage through
a French pressure cell at 130 MPa (SLM Instruments, Rochester,
N.Y.). Cell extracts (average, 15 mg of protein/ml) were
obtained by centrifugation at 18,000 × g for 20 min.
The cytoplasmic fraction was prepared by centrifugation at 100,000 × g for 45 min.
The enzyme enrichment was performed at 4°C under aerobic conditions
using a fast-performance liquid chromatography system
(Amersham
Pharmacia Biotech, Freiburg, Germany). The cytoplasmic
fraction
(average, 13 mg of protein/ml) was loaded onto a DEAE-Sephacel
(Amersham Pharmacia Biotech) column (6 by 2.5 cm) equilibrated
with 50 mM potassium phosphate buffer (pH 7.2). Elution was done
with a
gradient of KCl (0 to 1 mM) in 50 mM potassium phosphate
buffer (pH
7.2) at a flow rate of 2 ml/min. Fractions with taxifolin-transforming
activity were used for the characterization of the taxifolin
transformation
and the preparation of
alphitonin.
Determination of the taxifolin-transforming activity.
Taxifolin transformation was detected by HPLC analysis. The assay
contained 60 µM taxifolin (added from a 1.2 mM stock solution in
DMSO) in 50 mM potassium phosphate buffer (pH 6.9). The final DMSO
concentration was 5%. The reaction was started by the addition of cell
extract (average, 150 µg of protein), soluble enzyme fraction (average, 130 µg of protein), or partially purified enzyme
preparation (average, 42 µg of protein), respectively. The assay was
performed in the presence or absence of oxygen at room temperature. For HPLC analysis, samples were taken at different times and mixed with one
volume of methanol-H2O-acetic acid (50:45:5,
vol/vol/vol) to stop the reaction. Control reactions were devoid of
enzyme or contained enzyme preparations inactivated by incubation for 1 h at 50°C.
HPLC.
Flavonoids and aromatic metabolites were measured
using an HPLC system with a diode array detector (Gynkotek, Munich,
Germany). The HPLC system was equipped with a pump Model 480, degasser
ERC-5535, autosampler GINA 160, a column oven, a diode array detector
UVD-320, and a reversed-phase C18 column
(LiChroCART 250-4 LiChrospher 100 RP-18, 5 µm; 250 by 4 mm; Merck,
Darmstadt, Germany). The column temperature was maintained at 37°C.
Aqueous 0.1% trifluoroacetic acid (TFA) (solvent system A) and
methanol (solvent system B) served as the mobile phase in a gradient
mode (B from 5 to 30% in 20 min, from 30 to 50% in 5 min, from
50 to 80% in 10 min, from 80 to 100% in 4 min) with a flow rate of 1 ml/min and detection at 280 nm. TFA was replaced by aqueous 1.6%
formic acid (FA) for isolation of metabolites to be analyzed by mass
spectrometry. All compounds except alphitonin were identified by their
retention times and UV spectra (
= 200 to 355 nm) in comparison
to reference substances. Calibration curves were used for quantification.
Sample preparation for ESI-MS.
Selected incubation
supernatants from degradation experiments were used for identification
of the different compounds by electrospray ionization mass spectrometry
(ESI-MS). The samples (250 µl) were run on the HPLC system using the
FA-methanol gradient, and the different peaks were manually collected
for further analysis.
Mass spectrometry.
Coupled HPLC-ESI-MS or ESI-MS using flow
injection (10 µl/min) was performed depending on the purity and
concentration of the samples. Moreover, collision-induced dissociation
tandem mass spectrometry was carried out to obtain a specific fragmentation.
For analysis, a triple quadrupole mass spectrometer fitted with a
Z-spray API electrospray source (Quattro II; Micromass,
Manchester,
United Kingdom) was used. The HPLC system (2960; Waters,
Milford, Mass.) was equipped with a reversed-phase
C
18 column
(LiChroCART 250-4 LiChrospher 100 RP-18, 5 µm; 250 by 4 mm; Merck)
and a 996 PDA detector. The mobile
phase was a gradient of aqueous
formic acid and methanol similar to
those used for isolation of
the metabolites (described above) with a
flow rate of 0.5 ml/min
and was split 6:1 prior to introduction into
the mass spectrometer.
MS analyses were carried out in either positive
or negative ionization
mode. The temperature of the ion source was
maintained at 100°C.
The desolvation temperature was 350°C, and the
desolvation gas
N
2 had a flow rate of 400 liters/h. The cone and capillary voltage
used for the analysis of
quercetin and luteolin were 50 V and
3.7 kV, respectively, and 20 V and
3.0 kV for the analysis of
the metabolites. Product ion scans of
[M+H]
+ were performed at low-energy collisions
(15 to 30 eV) using argon
as the collision gas (1.5 × 10
2 to 2.8 × 10
2
mPa). The obtained molecular ion peaks and mass spectra were
compared to those of reference
substances.
In parallel to NMR analyses, the alphitonin and taxifolin preparations
were subjected to MS with electron impact ionization
(EI-MS, 70 eV)
using a Varian MAT CH6 spectrometer (Varian, Palo
Alto, Calif.). EI-MS
of taxifolin (
m/z, percent): 304 (M
+,
28), 275 (32), 153 (92), 123 (68). EI-MS of alphitonin (
m/z,
%): 304 (M
+, 12), 126 (100), 123
(75).
Preparation of alphitonin for NMR analysis.
Taxifolin (8.8 mg) was incubated with 4 ml of the partially purified
taxifolin-transforming preparation until no further alphitonin formation was observed (210 min). Samples of maximally 250 µl each
were injected onto the HPLC column. Alphitonin and the nontransformed taxifolin were separated using the TFA-methanol gradient. The fractions
of both substances were manually collected, pooled, and dried by vacuum
centrifugation (RC 10.22.; Jouan, Saint-Nazaire, France).
NMR analysis.
1H NMR spectra (300 MHz)
and 13C NMR spectra (75 MHz) were recorded on a
Varian Gemini 300 in DMSO-d6.
13C NMR signals were assigned on the basis of
attached proton test (APT). Nontransformed taxifolin, which was
obtained from the alphitonin preparation as described above, and
commercially available taxifolin gave identical
1H NMR spectra. 1H NMR of
taxifolin:
4.51 (dd, J = 11.2, 6.1 Hz, 1H, 3-H),
5.00 (d, J = 11.2 Hz, 1H, 2-H), 5.76 (d,
J = 6.1 Hz, 1H, 3-OH), 5.88, 5.93 (each d,
J = 2.0 Hz, 2H, 6-H, 8-H), 6.76 (s, br, 2H, 5'-H, 6'-H), 6.89 (s, br, 1H, 2'-H), 8.97, 9.03, 10.82, 11.91 (each s, 4H,
OH). 1H NMR of alphitonin:
2.82, 2.88 (each
d, J = 14.0 Hz, 2H, CH2), 5.73, 5.79 (each d, J = 1.8 Hz, 2H, 5-H, 7-H), 6.39 (dd,
J = 8.2, 1.9 Hz, 1H, 6'-H), 6.51 (d, J = 8.2 Hz, 1H, 5'-H), 6.56 (d, J = 1.9 Hz, 1H, 2'-H).
13C NMR of alphitonin:
41.55 (CH2), 90.39, 96.39 (C-5, C-7), 101.98 (C-2),
106.19 (C-3a), 115.65, 118.59 (C-2', C-5'), 121.93 (C-6'), 125.66 (C-1'), 144.45, 154.08 (C-3', C-4'), 158.64 (C-7a), 168.69, 172.56 (C-4, C-6), 193.60 (C-3).
 |
RESULTS |
In order to elucidate the pathways of flavonol and flavone
transformation by E. ramulus, the fermentation of quercetin
and luteolin by resting cells was investigated. Flavonoid conversion was followed by analysis of samples by HPLC. The individual samples were centrifuged, and the pellets were lyophilized and dissolved in
methanol. Dimethylformamide was less suitable as the solvent. Both the
resulting solution and the supernatant were examined. This method was
found to be advantageous compared to the lyophilization of the whole
sample because of a better recovery. The detected metabolites were
identified by their specific retention times using two different HPLC
gradients, and their UV spectra were recorded in the TFA-methanol
system. In addition, mass spectrometry was applied for confirmation of
the results.
In the first fermentation experiments using resting cells, only the
final products of flavonoid degradation were observed (data not shown).
However, intermediates could be observed by taking the samples
immediately after adding the substrates and decreasing the cell density
and the incubation temperature.
Quercetin degradation by resting cells of E.
ramulus.
Resting-cell suspensions of E. ramulus
degraded 1 mM quercetin to produce 0.8 mM 3,4-dihydroxyphenylacetic
acid within 4.8 h (Fig. 1A).
Retention times of quercetin were 31.5 min with the TFA-methanol
gradient (UV spectrum,
max = 260 nm) and 31.1 min with the FA-methanol gradient. Because of its low solubility in buffer, only small amounts of quercetin were recovered from the supernatant of the cell suspension. In contrast,
3,4-dihydroxyphenylacetic acid appeared exclusively in the supernatant.
The identity of the latter compound was confirmed on the basis of its
retention times (11.6 min, TFA-methanol gradient; 10.5 min, FA-methanol gradient) and UV spectrum (
max = 286 nm)
compared to the reference substance. MS analysis (flow injection) of
the product gave the expected [M+H]+ of
m/z 169 in the positive mode and
[M-H]
of m/z 167 in the negative
mode. The loss of 44 (CO2) resulting in
the in-source fragment ion m/z 123 was observed in the
negative mode and represents a typical fragmentation of phenolic acids (12). The degradation of quercetin was accompanied by the
formation of two transient soluble intermediates (Fig. 1B): one of
these was identified as taxifolin based on its retention times (25.4 min, TFA-methanol gradient; 23.9 min, FA-methanol gradient) and UV
spectrum (
max = 294 nm), which were identical
to those of the reference substance. ESI-MS analysis showed the
respective molecular ion peak of m/z 305 [M+H]+. The second intermediate with clearly
different retention times of 17.8 min (TFA-methanol gradient) and 16.3 min (FA-methanol gradient) exhibited a UV spectrum
(
max = 295 nm) similar to that of taxifolin.
ESI-MS analysis (LC-MS and direct injection) of this second
intermediate resulted in an ion peak of m/z 305 [M+H]+ which was identical to that of
taxifolin. However, in comparison to taxifolin a high rate of in-source
fragmentation occurred, characterized by relatively high intensities of
m/z 287 and m/z 259, indicating the loss of water
and CO, respectively (data not shown). For further characterization,
the compound was purified and the structure was elucidated by
1H and 13C NMR analysis
(see below). It was unambiguously identified as alphitonin
[2-(3,4-dihydroxbenzyl)-2,4,6-trihydroxybenzofuran-3-one], an
isomeric form of taxifolin. The MS/MS spectrum of alphitonin is shown
in comparison to that of taxifolin (Fig.
2). A reference substance was not
available.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
(A). Time course of quercetin degradation by resting
cells of E. ramulus (optical density at 600 nm, 12;
temperature, 37°C). The initial concentration of quercetin was 1 mM.
The concentrations of quercetin ( ), taxifolin ( ), alphitonin
( ), and 3,4-dihydroxyphenylacetic acid ( ) in the supernatant are
shown. It should be noted that the majority of the quercetin was
recovered from the pellet. (B). Initial phase of the degradation to
show the intermediates.
|
|

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 2.
Product ion spectra (MS/MS) of the m/z
305 [M+H]+ of alphitonin (A) and taxifolin (B). The MS/MS
spectrum of taxifolin shows a reverse-Diels-Alder fragment ion of
m/z 153, with high intensity. This fragment was not
observed in the case of alphitonin.
|
|
Degradation of taxifolin and alphitonin by resting cells of
E. ramulus.
Since taxifolin was identified as an
intermediate in the quercetin degradation pathway, its transformation
was studied with resting cells of E. ramulus (Fig.
3). The conversion of 1 mM taxifolin resulted in the formation of 3,4-dihydroxyphenylacetic acid. Small amounts of alphitonin were formed transiently. Besides the HPLC retention times and UV spectra, LC-MS measurements were utilized to
prove the identity of both substances. Incubation of 0.26 mM alphitonin
with resting cells of E. ramulus led to the
formation of 3,4-dihydroxyphenylacetic acid (Fig.
4). The identity of this compound was
confirmed by its retention times and UV and mass spectra. Using
LC-MS/MS, the same pattern of daughter ions of m/z 169 [M+H]+ (77, 123, 105) was observed for the
product formed from both taxifolin and alphitonin. The same pattern was
obtained for the reference substance of 3,4-dihydroxyphenylacetic acid.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 3.
Time course of taxifolin degradation by resting cells of
E. ramulus (optical density at 600 nm, 2.6; temperature,
19°C). The initial concentration of taxifolin was 1 mM.
Concentrations of taxifolin ( ), alphitonin ( ), and
3,4-dihydroxyphenylacetic acid ( ) are given.
|
|

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 4.
Time course of alphitonin degradation by resting cells
of E. ramulus (optical density at 600 nm, 6;
temperature, 19°C). The initial concentration of alphitonin was 0.26 mM. Concentrations of alphitonin ( ) and 3,4-dihydroxyphenylacetic
acid ( ) are given.
|
|
Transformation of taxifolin by cell extracts of E.
ramulus.
The transformation of taxifolin (60 µM) was
also catalyzed by cell extracts, the soluble enzyme fraction, and a
partially purified enzyme prepared from E. ramulus extracts
(Fig. 5), respectively. No transformation
was observed without the enzyme preparation or with an inactivated
enzyme preparation. The relatively small amount of taxifolin used in
these experiments was completely transformed to alphitonin as the final
product in the presence or absence of oxygen without the addition of
any coenzyme. The enriched enzyme preparation was also tested for
transformation of the dihydroflavone eriodictyol. However, neither with
nor without oxygen was a conversion observed.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 5.
Transformation of taxifolin by a partially purified
enzyme preparation of E. ramulus. The initial
concentration of taxifolin was 60 µM. Concentrations of taxifolin
( ) and alphitonin ( ) are given. For a control, taxifolin was
incubated without enzyme ( ).
|
|
Structural elucidation of alphitonin.
The alphitonin formed by
taxifolin transformation and purified by HPLC was highly pure as judged
by NMR analysis. Taxifolin was completely absent from this preparation.
By using the APT technique, alphitonin could be distinguished from
taxifolin due to the CH2 signal in the
13C NMR spectrum of alphitonin (Fig.
6). The structure of alphitonin could be
unequivocally deduced from the NMR data. In particular, 13C and 1H NMR signals
indicated that the ring A was being nonsymmetrically substituted. Thus,
a ring-open chalcone structure could be excluded. According to the
structure of alphitonin, a signal for the benzylic carbon (41.55 ppm)
was assigned; the diastereotopic hydrogens gave two doublets (2.82, 2.88 ppm; J = 14.0 Hz).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 6.
13C NMR (APT) spectrum of alphitonin,
obtained from taxifolin transformation by an enzyme preparation of
E. ramulus followed by purification with HPLC.
Using the APT technique, downward signals indicate CH3 and
CH carbons, whereas upward signals indicate CH2 and C
carbons.
|
|
Luteolin degradation by resting cells of E.
ramulus.
Resting cells of E. ramulus were also
used to investigate the degradation of the flavone luteolin, whose
structure lacks the 3-hydroxyl group present in quercetin. Luteolin
(0.5 mM; TFA-methanol and FA-methanol gradients, 32.4 min,
max = 348 nm) was transformed via the
intermediate eriodictyol to 0.4 mM 3-(3,4-dihydroxyphenyl)propionic acid within 120 min (Fig. 7). Luteolin
was found exclusively in the pellet of the centrifuged samples.
Eriodictyol was predominantly recovered from the supernatant, whereas
the pellet contained approximately 10% of this compound. The
final product, 3-(3,4-dihydroxyphenyl)propionic acid, was almost
exclusively found in the supernatant. The identity of eriodictyol was
confirmed by its retention times (29.8 min, TFA-methanol gradient; 29.2 min, FA-methanol gradient) and UV spectrum
(
max = 294 nm). Similarly, the identity of
3-(3,4-dihydroxyphenyl)propionic acid as the product of the luteolin
degradation was demonstrated on the basis of its retention times (16.3 min, TFA-methanol gradient; 14.5 min, FA-methanol gradient) and UV
spectrum (
max = 286 nm). MS analysis (flow
injection) gave the expected molecular ion peaks of eriodictyol
(m/z 289 [M+H]+) and
3-(3,4-dihydroxyphenyl)propionic acid (m/z 183 [M+H]+, m/z 181 [M-H]
).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 7.
Time course of luteolin degradation by resting cells of
E. ramulus (optical density at 600 nm, 6; temperature,
19°C). The initial concentration of luteolin was 0.5 mM. The
concentrations of luteolin ( ), eriodictyol ( ), and
3-(3,4-dihydroxyphenyl)propionic acid ( ) recovered from the
supernatant and the pellet are shown. Immediately after starting the
transformation a luteolin concentration of 0.22 mM was observed,
probably as a result of very fast uptake and metabolization.
|
|
 |
DISCUSSION |
These investigations were done in order to get insight into the
pathway of flavonoid degradation by a relevant bacterial species of the
human intestinal tract, E. ramulus. The flavonol quercetin was chosen because quercetin glycosides are highly abundant dietary flavonoids. The ability of E. ramulus to grow on
quercetin-3-glucoside was previously shown. Quercetin and
phloroglucinol were detected as intermediates in the
transformation of quercetin-3-glucoside. The formation of
phloroglucinol indicated that E. ramulus is capable of
splitting the heterocyclic C-ring of quercetin (20).
The degradation of quercetin was also reported for other human
intestinal bacteria and for species from the bovine rumen. Examples
include Butyrivibrio sp. C3 (4),
Clostridium orbiscindens (22),
Pediococcus Q-05 (16), and Eubacterium
oxidoreducens (17). In contrast to E. oxidoreducens, which is able to grow on the aglycon quercetin as
the sole carbon and energy source in the presence of hydrogen or
formate as reductants (17), the growth of E. ramulus with quercetin was strictly dependent on glucose, which
could be replaced neither by hydrogen nor by formate (20).
However, as described herein, resting cells of E. ramulus
are able to convert quercetin and its flavone analogue, luteolin. This
offered the opportunity to study these transformations quantitatively
in the absence of glucose and other media components.
In accordance with previous reports using growing cultures (19,
20), quercetin was transformed by resting cells of E. ramulus to 3,4-dihydroxyphenylacetic acid (Fig. 1 and structures in Fig. 8). In the course of
fermentation, the enol carbon C-3 is transformed to the carboxyl group
of 3,4-dihydroxyphenylacetic acid. Thus, this bacterial degradation
of quercetin does not occur via reverse reactions of its biosynthesis
in plants. In the quercetin synthesis pathway of plants (for a review,
see reference 6), the intermediate taxifolin is formed by
hydroxylation of eriodictyol (structure in Fig.
9).
Two intermediates of the quercetin degradation were identified,
taxifolin and alphitonin (Fig. 1). Separate experiments showed that
both taxifolin and alphitonin were transformed to
3,4-dihydroxyphenylacetic acid (Fig. 3 and 4). The degradation of
taxifolin to 3,4-dihydroxyphenylacetic acid is in accordance with
previous results using growing cells of E. ramulus
(19). Alphitonin was identified as an intermediate of the
conversion of taxifolin to 3,4-dihydroxyphenylacetic acid (Fig. 3).
From these data, the pathway of the quercetin degradation shown in Fig.
8 could be deduced. It starts with the reduction of the double bond in
the 2,3-position of quercetin, resulting in the formation of taxifolin.
The following ring contraction to the identified isomeric alphitonin
probably occurs by a ring opening-recyclization mechanism via a
chalcone or diketone structure. However, this postulated chalcone (or
tautomeric diketone) could not be observed, presumably because
of the fast cyclization to alphitonin. We cannot distinguish whether
this cyclization is part of an enzyme-catalyzed reaction or whether it
occurs spontaneously. Neither the
-hydroxychalcone
[2-hydroxy-3-(3,4-dihydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propenone] nor the diketone
[3-(3,4-dihydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propane-1,2-dione] have been described in the literature so far. As a result of the ring
contraction to alphitonin, a benzylic CH2 group
is already formed as it finally appears in the product,
3,4-dihydroxyphenylacetic acid. An oxidative decarboxylation step is
postulated for the conversion of alphitonin to phloroglucinol and
3,4-dihydroxyphenylacetic acid. Whereas 3,4-dihydroxyphenylacetic acid
was identified as a final product, phloroglucinol was shown to undergo
further degradation to butyrate and acetate (L. Schoefer, personal communication).
This is the first report describing alphitonin as an intermediate of
bacterial metabolism. The elucidation of structure became necessary
because a reference substance for this compound was not available, and
the molecular masses of alphitonin and the corresponding chalcone
structure are identical. The structure of alphitonin was unambiguously
deduced from the NMR data, which were in agreement with the data
reported by Kiehlmann and Li (14). These authors
demonstrated the nonenzymatic isomerization of taxifolin to alphitonin
under drastic conditions (115°C for 4 days). The structure of
alphitonin, isolated from the heartwood of Alphitonia excelsa, was reported in 1960 (1). The compound was
also identified in the wood of Alphitonia petriei but not in
that of Alphitonia whitei (7). Remarkably, no
studies on the biological activity of alphitonin have been reported so
far. Our results, however, indicate that alphitonin appears as an
intermediate of intestinal metabolism of the abundant flavonoid
quercetin and might be absorbed in the human intestinal tract.
We also investigated the degradation of the flavone luteolin by resting
cells of E. ramulus. The proposed degradation pathway is
shown in Fig. 9. Initial reduction led to the formation of eriodictyol,
similar to the transformation of quercetin to taxifolin. Eriodictyol
was identified as an intermediate in the resting-cell fermentation
(Fig. 7). By the ensuing ring cleavage, a chalcone structure could be
formed which may be further reduced to a dihydrochalcone. However,
neither of these compounds nor a fused five-membered structure similar
to alphitonin was observed. The final product of luteolin degradation
was 3-(3,4-dihydroxyphenyl)propionic acid, which was identified in
fermentation experiments with resting cells (Fig. 7), comparable to the
results obtained previously with growing cells of E. ramulus
(19), which fermented luteolin and eriodictyol in the
presence of glucose. Phloroglucinol is certainly another intermediate,
as postulated for several flavonoid degradation pathways (9, 18,
22), but its further degradation occurred instantly. Similar to
our results, it was reported that eriodictyol is converted to
3-(3,4-dihydroxyphenyl)propionic acid by a strain of Clostridium
butyricum (18).
The comparison of the pathways (Fig. 8 and 9) reveals that degradation
of both quercetin and luteolin by E. ramulus starts with the
reduction of the double bond in the 2,3- position prior to the C-ring
fission. The steps that follow differ due to the 3-hydroxyl group in
the quercetin molecule, which is the only difference from the luteolin
structure. This hydroxyl group seems to be a prerequisite for the
formation of the alphitonin structure following C-ring cleavage. In
contrast, the fission of the heterocyclic ring of eriodictyol, which
results from luteolin, would lead directly to a chalcone structure, and
for further transformation a second reduction step is assumed. These
postulated intermediates could not be observed during luteolin
conversion by resting cells, although such chalcones and
dihydrochalcones are known to be stable (6). It was shown
previously that the dihydrochalcone phloretin is also degraded by
growing cells of E. ramulus in the presence of glucose
(19). The final products resulting from the B-ring of quercetin and luteolin, respectively, differ in one carbon atom within
the side chain, indicating an additional decarboxylation step in the
case of quercetin degradation. The notion that the degradation of
flavonols and flavones by E. ramulus occurs by two different
pathways and involves different enzymes is supported by the finding
that the taxifolin-transforming enzyme preparation did not transform
eriodictyol, either in the presence or in the absence of oxygen (data
not shown).
In conclusion, the fermentation by resting cells constitutes an
advantageous method for the detection of intermediates of flavonoid
degradation by intestinal bacteria. These bacterial metabolites should
be included in investigations concerning the flavonoid effects after
ingestion by humans. However, the characterization of the involved
enzymes and the reaction mechanisms requires further studies with
cell-free systems. This approach has already been initiated for the
taxifolin isomerization as described above, and it will be continued in
ongoing studies in our laboratories.
 |
ACKNOWLEDGMENTS |
This work was supported in part by the Deutsche
Forschungsgemeinschaft (grant no. INK 26/A1-1, B1-1).
We thank Sabine Zimmerman for technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Deutsches
Institut für Ernährungsforschung, Abteilung
Gastrointestinale Mikrobiologie, Arthur-Scheunert-Allee 114-116, D-14558 Bergholz-Rehbrücke, Germany. Phone: 49 33200-88402. Fax:
49 33200-88407. E-mail: braune{at}www.dife.de.
Present address: Pharmazeutisches Institut, Poppelsdorf,
Universität Bonn, D-53115 Bonn, Germany.
 |
REFERENCES |
| 1.
|
Birch, A. J.,
E. Ritchie, and R. N. Speake.
1960.
The structure of alphitonin.
J. Chem. Soc.
1960:3593-3599[CrossRef].
|
| 2.
|
Bokkenheuser, V. D.,
C. H. Shackleton, and J. Winter.
1987.
Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans.
Biochem. J.
248:953-956[Medline].
|
| 3.
|
Bryant, M. P.
1972.
Commentary on the Hungate technique for culture of anaerobic bacteria.
Am. J. Clin. Nutr.
25:1324-1328[Free Full Text].
|
| 4.
|
Cheng, K. J.,
G. A. Jones,
F. J. Simpson, and M. P. Bryant.
1969.
Isolation and identification of rumen bacteria capable of anaerobic rutin degradation.
Can. J. Microbiol.
15:1365-1371[Medline].
|
| 5.
|
de Vries, J. H.,
P. L. Janssen,
P. C. Hollman,
W. A. van Staveren, and M. B. Katan.
1997.
Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets.
Cancer Lett.
114:141-144[CrossRef][Medline].
|
| 6.
|
Dimmock, J. R.,
D. W. Elias,
M. A. Beazely, and N. M. Kandepu.
1999.
Bioactivities of chalcones.
Curr. Med. Chem.
6:1125-1149[Medline].
|
| 7.
|
Guise, G. B.,
E. Ritchie, and W. C. Taylor.
1962.
Further constituents of Alphitonia species.
Aust. J. Chem.
15:314-321.
|
| 8.
|
Harborne, J. B., and C. A. Williams.
2000.
Advances in flavonoid research since 1992.
Phytochemistry
55:481-504[CrossRef][Medline].
|
| 9.
|
Hattori, M.,
Y. Z. Shu,
A. I. el-Sedawy,
T. Namba,
K. Kobashi, and T. Tomimori.
1988.
Metabolism of homoorientin by human intestinal bacteria.
J. Nat. Prod.
51:874-878[CrossRef][Medline].
|
| 10.
|
Hertog, M. G.,
P. C. Hollman,
M. B. Katan, and D. Kromhout.
1993.
Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands.
Nutr. Cancer
20:21-29[Medline].
|
| 11.
|
Hungate, R. E.
1969.
A roll tube method for cultivation of strict anaerobes, p. 117-132.
In
J. R. Norris, and D. W. Ribbons (ed.), Methods in microbiology, vol. 3B. Academic Press, New York, N.Y.
|
| 12.
|
Justesen, U., and E. Arrigoni.
2001.
Electrospray ionisation mass spectrometric study of degradation products of quercetin, quercetin-3-glucoside and quercetin-3-rhamnoglucoside, produced by in vitro fermentation with human faecal flora.
Rapid Commun. Mass Spectrom.
15:477-483[CrossRef][Medline].
|
| 13.
|
Justesen, U.,
P. Knuthsen, and T. Leth.
1997.
Determination of plant polyphenols in Danish foodstuffs by HPLC-UV and LC-MS detection.
Cancer Lett.
114:165-167[CrossRef][Medline].
|
| 14.
|
Kiehlmann, E., and E. P. M. Li.
1995.
Isomerization of dihydroquercetin.
J. Nat. Prod.
58:450-455[CrossRef].
|
| 15.
|
Kim, D. H.,
E. A. Jung,
I. S. Sohng,
J. A. Han,
T. H. Kim, and M. J. Han.
1998.
Intestinal bacterial metabolism of flavonoids and its relation to some biological activities.
Arch. Pharm. Res.
21:17-23[Medline].
|
| 16.
|
Kim, D.-H.,
S.-B. Han,
E.-A. Bae, and M. J. Han.
1996.
Intestinal bacterial metabolism of rutin and its relation to mutagenesis.
Arch. Pharm. Res.
19:41-45.
|
| 17.
|
Krumholz, L. R.,
R. L. Crawford,
M. E. Hemling, and M. P. Bryant.
1986.
A rumen bacterium degrading quercetin and trihydroxybenzenoids with concurrent use of formate or H2.
Prog. Clin. Biol. Res.
213:211-214[Medline].
|
| 18.
|
Miyake, Y.
1997.
Metabolism of antioxidant in lemon fruit (Citrus limon BURM. f.) by human intestinal bacteria.
J. Agric. Food Chem.
45:3738-3742[CrossRef].
|
| 19.
|
Schneider, H., and M. Blaut.
2000.
Anaerobic degradation of flavonoids by Eubacterium ramulus.
Arch. Microbiol.
173:71-75[CrossRef][Medline].
|
| 20.
|
Schneider, H.,
A. Schwiertz,
M. D. Collins, and M. Blaut.
1999.
Anaerobic transformation of quercetin-3-glucoside by bacteria from the human intestinal tract.
Arch. Microbiol.
171:81-91[CrossRef][Medline].
|
| 21.
|
Simmering, R.,
B. Kleessen, and M. Blaut.
1999.
Quantification of the flavonoid-degrading bacterium Eubacterium ramulus in human fecal samples with a species-specific oligonucleotide hybridization probe.
Appl. Environ. Microbiol.
65:3705-3709[Abstract/Free Full Text].
|
| 22.
|
Winter, J.,
M. R. Popoff,
P. Grimont, and V. D. Bokkenheuser.
1991.
Clostridium orbiscindens sp. nov., a human intestinal bacterium capable of cleaving the flavonoid C-ring.
Int. J. Syst. Bacteriol.
41:355-357[Abstract/Free Full Text].
|
Applied and Environmental Microbiology, December 2001, p. 5558-5567, Vol. 67, No. 12
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.12.5558-5567.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hanske, L., Loh, G., Sczesny, S., Blaut, M., Braune, A.
(2009). The Bioavailability of Apigenin-7-Glucoside Is Influenced by Human Intestinal Microbiota in Rats. J. Nutr.
139: 1095-1102
[Abstract]
[Full Text]
-
Matthies, A., Clavel, T., Gutschow, M., Engst, W., Haller, D., Blaut, M., Braune, A.
(2008). Conversion of Daidzein and Genistein by an Anaerobic Bacterium Newly Isolated from the Mouse Intestine. Appl. Environ. Microbiol.
74: 4847-4852
[Abstract]
[Full Text]
-
Ruiz, P. A., Braune, A., Holzlwimmer, G., Quintanilla-Fend, L., Haller, D.
(2007). Quercetin Inhibits TNF-Induced NF-{kappa}B Transcription Factor Recruitment to Proinflammatory Gene Promoters in Murine Intestinal Epithelial Cells. J. Nutr.
137: 1208-1215
[Abstract]
[Full Text]
-
Blaut, M., Clavel, T.
(2007). Metabolic Diversity of the Intestinal Microbiota: Implications for Health and Disease. J. Nutr.
137: 751S-755S
[Abstract]
[Full Text]
-
Wang, X.-L., Hur, H.-G., Lee, J. H., Kim, K. T., Kim, S.-I.
(2005). Enantioselective Synthesis of S-Equol from Dihydrodaidzein by a Newly Isolated Anaerobic Human Intestinal Bacterium. Appl. Environ. Microbiol.
71: 214-219
[Abstract]
[Full Text]
-
Schoefer, L., Braune, A., Blaut, M.
(2004). Cloning and Expression of a Phloretin Hydrolase Gene from Eubacterium ramulus and Characterization of the Recombinant Enzyme. Appl. Environ. Microbiol.
70: 6131-6137
[Abstract]
[Full Text]
-
Schoefer, L., Mohan, R., Schwiertz, A., Braune, A., Blaut, M.
(2003). Anaerobic Degradation of Flavonoids by Clostridium orbiscindens. Appl. Environ. Microbiol.
69: 5849-5854
[Abstract]
[Full Text]